Enveric Biosciences, INC S-1 registration statements

Enveric Biosciences has filed an amendment to its S-1 registration statement, primarily to include updated exhibits related to its financial and legal agreements.

Enveric Biosciences is seeking to raise capital through an offering of common stock, pre-funded warrants, and accompanying Series A and Series B warrants.

Enveric Biosciences is offering shares of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants, to raise capital for product development and general corporate purposes.

Enveric Biosciences has filed a registration statement for the resale of up to 4.9 million shares of its common stock by Lincoln Park Capital Fund, potentially generating gross proceeds of $2.45 million.